The synovial and systemic pharmacokinetics and pharmacodynamics of intra-articular administration of the CSF1 receptor antibody AMB-05X in a phase II proof-of-concept trial in tenosynovial giant cell tumor

被引：1

作者：

Gelderblom, H. ^{[1
]}

Huang, M. ^{[2
]}

van de Sande, M. ^{[3
]}

Scharschmidt, T. ^{[4
]}

Kostogryz, O. ^{[5
]}

Alani, L. ^{[2
]}

Huang, T. ^{[2
]}

Hsu, L. ^{[2
]}

Johnson, K. ^{[2
]}

机构：

[1] LUMC, Dept Med Oncol, Leiden, Netherlands

[2] AmMax Bio, R&D, Redwood City, CA USA

[3] Leiden Univ Med Ctr, Orthoped Oncol Dept, Leiden, Netherlands

[4] Ohio State Univ Med Ctr, Orthoped Oncol Dept, Columbus, OH USA

[5] NAMS, Inst Traumatol & Orthoped, Orthoped Oncol Dept, Kiev, Ukraine

来源：

关键词：

D O I：

10.1016/j.annonc.2022.07.1589

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1486MO

引用

页码：S1226 / S1226

页数：1